Statin tolerability: In defence of placebo-controlled trials

BACKGROUND: Statin intolerance is a barrier to effective lipid-lowering treatment. A significant number of patients stop prescribed statins, or can take only a reduced dose, because of adverse events attributed to the statin, and are then considered statin-intolerant. METHODS: Examination of differe...

Descripción completa

Detalles Bibliográficos
Autores principales: Tobert, Jonathan A, Newman, Connie B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2015
Materias:
Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847124/
https://www.ncbi.nlm.nih.gov/pubmed/26318980
http://dx.doi.org/10.1177/2047487315602861

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847124/
https://www.ncbi.nlm.nih.gov/pubmed/26318980
http://dx.doi.org/10.1177/2047487315602861

Ejemplares similares